Results 51 to 60 of about 2,487,122 (258)
François Pluvinage, Éric Roditi
doaj +1 more source
Editorial - Volume 21, Issue 4
Rory McGreal
doaj +1 more source
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source
Editorial - Volume 21, Issue 3
Constance Blomgren
doaj +1 more source
Editorial: JANZSSA Volume 21 Issue 1, April 2013
Editorial: JANZSSA Volume 21 Issue 1, April ...
Cathy Stone, Annie Andrews
doaj
Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma
Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski +10 more
wiley +1 more source
Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht +3 more
wiley +1 more source
Editorial: JANZSSA Volume 21 Issue 2, October 2013
Editorial: JANZSSA Volume 21 Issue 2, October ...
Cathy Stone, Annie Andrews
doaj

